Abstract
The synthesis of a series of phenethanolamine aniline agonists that contain an aniline ring on the right-hand side of the molecule substituted at the meta position with a benzoic acid or a pyridyl carboxylate is described. Several of the analogues (e.g., 34, 36-38, 40, and 44) have high beta(3) adrenergic receptor (AR) potency and selectivity against beta(1) and beta(2) ARs in Chinese hamster ovary (CHO) cells expressing beta ARs. The dog pharmacokinetic profile of some of these analogues showed >25% oral bioavailability and po half-lives of at least 1.5 h. Among the compounds described herein, the 3,3'-biarylaniline carboxylate derivatives 36, 38 and the phenylpyridyl derivative 44 demonstrated outstanding in vitro properties and reasonable dog pharmacokinetic profiles. These three analogues also showed dose dependent beta(3) AR mediated responses in mice. The ease of synthesis and superior dog pharmacokinetics of compound 38 relative to that of 44 in combination with its in vitro profile led us to choose this compound as a development candidate for the treatment of type 2 diabetes.
References
Sep 8, 1989·Science·L J EmorineA D Strosberg
Mar 1, 1996·Mutagenesis·D A BurkeB Burlinson
Oct 1, 1996·Trends in Pharmacological Sciences·A D Strosberg, F Pietri-Rouxel
Jul 1, 1998·Pharmaceutical Research·M A PaulikJ M Lenhard
Oct 20, 1998·Acta Physiologica Scandinavica·Y IgawaO Nishizawa
Apr 3, 1999·British Journal of Pharmacology·Y IgawaK E Andersson
Jun 18, 1999·Cardiovascular Drugs and Therapy·C Smith, M Teitler
Oct 29, 2000·Journal of Medicinal Chemistry·R J MathvinkA E Weber
Jan 25, 2002·Journal of Medicinal Chemistry·David E UehlingConrad Cowan
Jun 4, 2002·Current Drug Targets·M H Moneva, S Dagogo-Jack
Sep 27, 2002·The American Journal of Clinical Nutrition·Thomas M LarsenArne Astrup
Oct 4, 2002·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Rajkumar SevakDevdas Santani
Citations
Dec 25, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Yasuhiko Igawa, Martin C Michel
Jun 15, 2007·Bioorganic & Medicinal Chemistry Letters·Barry G ShearerFrank Lee
May 4, 2011·Journal of Chemical Information and Modeling·Kuldeep K Roy, Anil K Saxena
Jan 6, 2015·Expert Opinion on Investigational Drugs·Pamela Ellsworth, Jennifer Fantasia
Jul 17, 2007·Gastroenterology·Selim CellekKevin Lee
Jan 19, 2010·Angewandte Chemie·Masayuki WasaJin-Quan Yu
Jul 1, 2015·Journal of Medicinal Chemistry·Yasuhiro WadaSatoshi Shuto
Jan 26, 2016·Pharmacology & Therapeutics·Martin C Michel, Cees Korstanje
Mar 29, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·April B M GrudellAlan R Zinsmeister
Jul 14, 2007·The Journal of Pharmacology and Experimental Therapeutics·Alexandra HicksJ Paul Hieble
Jun 1, 2011·Molecular Diversity·Ming HaoShuwei Zhang
Mar 15, 2019·British Journal of Pharmacology·Yasuhiko IgawaMartin C Michel
Jul 3, 2019·Frontiers in Pharmacology·Katerina OkekeMartin C Michel
Mar 2, 2021·Frontiers in Pharmacology·Gabriela Reolon PassosFabiola Zakia Mónica
Jul 25, 2008·Journal of Medicinal Chemistry·Masashi ImanishiKouji Hattori
Jan 21, 2014·Journal of Medicinal Chemistry·Christopher R MoyesScott D Edmondson
Feb 18, 2015·The Journal of Organic Chemistry·Robin HertzbergChristina Moberg
Dec 18, 2007·Bioorganic & Medicinal Chemistry·Maria Grazia PerroneAntonio Scilimati
Mar 1, 2008·Journal of Medicinal Chemistry·Masashi ImanishiKouji Hattori